Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
Recruiting now · Not applicable
Conditions studied: Head and Neck Cancer
In brief
The goal of this study is to evaluate the safety and efficacy of the stereotactic boost applied in patients with H\&N tumours.
Key facts
- Study ID
- NCT06472570
- Run by
- Maria Sklodowska-Curie National Research Institute of Oncology
- People needed
- 80
- Starts
- 2019-10-26
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2024-06-25
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with squamous cell carcinoma (SCC) or adenoid cystic carcinoma (ACC) of the H\&N region qualified for radical treatment with (definitive or adjuvant (adjuvant radiotherapy or radiochemotherapy in postoperative cases of R2 resection or early locoregional recurrence unsuitable for reoperation)) radiotherapy or radiochemotherapy.
- Patients with other malignant tumours of the H\&N region (sarcomas, neuroendocrine carcinomas, differentiated carcinomas, undifferentiated carcinomas, or basaloid carcinomas) qualified for radical treatment with (definitive or adjuvant (adjuvant radiotherapy or radiochemotherapy in postoperative cases of R2 resection or early locoregional recurrence unsuitable for reoperation)) radiotherapy or radiochemotherapy.
- Patients with nonmalignant tumours of the H\&N region (tumour mixtus or paraganglioma) demanding definitive or adjuvant radiotherapy.
- Age: 18-80 years. Biomedicines 2022, 10, 1484 5 of 12
- Performance status: Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2.
- Conscious agreement to participate in the clinical trial.
You may not qualify if…
- Do not meet the inclusion criteria.
- Decompensated diabetes mellitus.
- Myocardial infarction occurred up to 6 months before.
- Pregnancy.
- Mental disorder preclusive of making a conscious agreement
Where it is running
- 1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, — Gliwice, Gliwicw, Poland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.